ATV Capital

What is ATV Capital?

Lightstone Ventures is an investment fund that specializes in funding novel, disruptive technologies with a primary focus on the biotech and medtech industries. Their mission is to transform patients' lives by supporting visionary founders who aim to translate groundbreaking scientific breakthroughs into clinically and commercially significant therapies.

The fund provides patient capital and adopts a thesis-driven investment strategy that involves a deep understanding of key market sectors and the identification of transformative technologies. With a team of experienced life science investors and nearly 100 years of combined operational experience, they back companies not only financially but also by partnering with them to navigate their everyday challenges and establishing strategies for commercial viability.

Lightstone Ventures stands apart through their hands-on approach with founders and their dedication to company building. They emphasize investing in people, not just ideas, understanding that the success of a company relies heavily on the talent and ambition of its team.

The firm looks for first-in-class drugs, targeting central nervous system (CNS), immunology, oncology, and ophthalmology within the biotech space while in medtech, they focus on companies at the convergence of technology, medicine, and consumer health, including personalized medicines and targeted therapeutics.

Their global footprint with offices in the US and Ireland expands their reach and ability to secure non-US strategic and financial funding sources.

Lightstone Ventures' track record boasts involvement in multiple successful life science exits including IPOs and acquisitions, reinforcing their capability as guides through a company's lifecycle. Their portfolio reflects their commitment to building successful companies that can pursue impactful treatments and therapies for patients, spanning from early ventures to those ready for commercialization.